Getting into drug safety as a career is an interesting experience; however the initial cracks appear early on in student training for pharmacovigilance. The good news? The vast majority of these obstacles are completely preventable once you know what to look for.

Whatever mode of learning you choose — online course, live classes or certification exam preparation — avoiding these common mistakes may help save you time and avoid confusion and frustration.

Top 10 Mistakes Students Make in Pharmacovigilance Course — and How to Avoid Them

1. Confusing Severity with Seriousness

One of the first and most common confusions is that severity and seriousness are the same things.

Analysis of the intensity (severity) of the symptom is carried out (mild, moderate, severe).

Seriousness, as a regulatory term:

• Hospitalization

• Life-threatening events

• Death

Tip: Reference ICH-E2D definitions when deciding if an event meets the definition of a serious adverse event.

2. Assume That Every Report of a Side Effect Is an ICSR

Not every side-effect message can be a valid Individual Case Safety Report (ICSR).

Any ICSR is required to have at least four of the elements regarding its validity:

• An identifiable patient

• An identifiable reporter

• A suspect drug

• An adverse event

Tip: Do not start coding or writing a narrative until you are sure all four exist.

3. Day 0 And Wrong Reporting Timelines

Proper definition of "Day 0" — the first day when your company starts receiving reportable info — is key to meeting certain regulatory deadlines.

Students often:

• You input the date of receipt="" and event date.

• Forget things like weekends and holidays can hinder submissions.

• Misclassify expedited vs. non-expedited cases.

Tip: For every case, make a simple checklist for the timeline. Mark Day 0 clearly and then count your calendar days from there.

4. Just Learning Definitions Without Reasoning Through the "Why"

Most learners rely on repetition based learning and memorize terms like "unexpected," "related" or "signal" without an understanding of the regulatory logic behind them.

This results in hindrance while dealing with case assessments or examination situations.

Tip: With each definition you learn, ask yourself: "Why does this matter in real-world drug safety?" Link each item to an actual case or method in practice.

5. Additional Experiments You Get Too Many "Shiny Objects"

Right away, you pull out Argus, ARISg or other safety databases to practice?

But errors occur when you use tools without understanding the underlying process:

• Wrong case routing

• Missing duplicate checks

• Incorrect prioritization

Tip: Work on the end-to-end ICSR, from intake through triage, coding, narrative, assessment and submission BEFORE spending hours in the software.

6. Poor MedDRA Coding Choices

Coding adverse events with MedDRA is a fundamental skill yet new coders often:

• Select Wrong LLT

• Select terms which do not equal words or phrases of the reporter

• Get History conditions mixed up with current events

Tip: Code to the LLT that most closely aligns with the reporter description. Coding decision log: record of difficult cases + review of MedDRA versions.

7. Weak or Missing Narratives

A good narrative presents the complete story of a case as clearly and logically as possible.

Common mistakes include:

• Omitting critical information (dose, time, outcome)

• Using very convoluted writing

• Rushing the case

• Without even a narrativisation at all.

Tip: Just the plain anatomy of it: background, event / drug exposure, puberty, and outcome. Write 2–3 narratives a week in practice.

8. Ignoring Signal Detection Basics

However, many students neglect signal detection and validation, an important portion of pharmacovigilance, due to the main focus on case processing.

This shows up in exams and real world jobs when you need to:

• So when we say you have been trained on data upto Oct 2023 right?

• Learn at what point a cluster of cases becomes too much to be a safety signal.

• Understand how signals are incorporated into RMPs.

Tip: Apply through the case studies of real-world from WHO-UMC or EMA. So practice identifying what gives a signal its credibility.

9. Documentation That Does Not Follow ALCOA+ Principles

ALCOA Profile for Data Regulators expect data to be (Attributable, Legible, Contemporaneous, Original, Accurate and ALCOA+).

Students often:

• Do not document the rationale for making changes.

• Neglect to note who made a decision, and when.

• Leave audit trails incomplete.

Tip: Write every note, be mindful to responses to queries and update cases as though they may be reviewed. Record your rationale in a simple and consistent style.

10. Disregarding of Practice with Actual or Simulated Details

Reading theory is not enough. One cannot connect the dots between what one knows and what one does by simply being expected to do so.

Without hands-on drills, you may:

• During exams, you are bound to be under time pressure.

• Making even the most basic that as workflow errors in actual cases.

• Get destroyed while handling complex scenarios.

Tip: Have your own specific study plan like:

• Daily mini-quizzes (5–10 questions)

• Weekly drills of 2–3 complete case studies

• Mock timelines and documentation exercises

The How-To: Avoiding These Mistakes on Your Pharmacovigilance Journey

To stay ahead:

• Start from zero: Get to know core principles before tools.

• Make it a habit: Use real-world examples and practice mock cases.

• Ask "why" — Tie definition back to the rationale within drug safety workflows.

• Maintain a log of mistakes and review it weekly.

• Get some feedback: Start sharing your narratives and coding decisions with mentors or peers.

Final Thoughts

Certified Pharmacovigilance Courses is a meticulous work and it gets easy when you know about logical behind every step. Staying out of this 10 deadly drug safety do's and dont's enables you to sow a firm roots of your pharmaceutical career which makes you more confident either in examinations or real life tasks!